相关实验视频
Updated: Sep 10, 2025

10:41
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
14.2K
伦瓦提尼布相关的非结核菌性肺病:一个病例报告
Qian Wang1, Lili Du1, Yiming Wang1
1Department of Respiratory and Critical Care Medicine Huangshan City People's Hospital Huangshan Anhui China.
Respirology case reports
|August 22, 2025
概括
一名患有肝癌的患者因Mycobacterium kansasii感染而发作咳. 停药改善了症状和肺部病变,突出显示了药物诱导的潜在感染.
科学领域:
- 肝细胞癌研究
- 传染病诊断
- 癌症药物的副作用
背景情况:
- 肝细胞癌 (HCC) 的治疗通常涉及向治疗,如伦瓦替尼.
- 伦瓦提尼布是一种多酶抑制剂,可能会产生各种副作用.
- 机会性感染可能发生在免疫受损患者或长期治疗患者中.
研究的目的:
- 报告一种罕见的 Mycobacterium kansasii 感染病例,该病例发生在接受 lenvatinib 治疗 HCC 的患者中.
- 调查伦瓦替尼治疗与非典型感染的发展之间的潜在关联.
- 描述这种情况下的诊断挑战和管理结果.
主要方法:
- 一个64岁的男性患有HCC治疗lenvatinib的病例报告
- 诊断包括支气管镜检查和洗液分析.
- 使用下一代测序 (NGS) 来识别病原体.
- 临床治疗包括药物停用和症状监测.
主要成果:
- 通过支气管检查进行的初始病原体检测结果为阴性.
- 下一代测序 (NGS) 确定了Mycobacterium kansasii的存在.
- 停用林瓦替尼导致咳和胸部紧张感显著改善.
- 随访胸部CT显示肺病变完全消失.
结论:
- 在接受伦瓦提尼布治疗的患者出现呼吸道症状时,应考虑感染Mycobacterium kansasii.
- 下一代测序 (NGS) 是诊断具有挑战性的感染的一个有价值的工具.
- 停止使用伦瓦替尼可能是治疗这种机会性感染的关键步骤.
相关概念视频
Pulmonary Tuberculosis V
238
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
238
Pulmonary Tuberculosis I
324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Pulmonary Tuberculosis IV
204
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
204
Pulmonary Tuberculosis III
442
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
442
Pulmonary Tuberculosis II
345
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
345
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K

